Genetics study for schizophrenia in Manitoba
Part of Mental health clinical trials.
This study looks at genetic factors linked to schizophrenia by analyzing data from people who are already in certain mental health programs in Manitoba. It may help find better ways to treat or support people with schizophrenia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You live in Manitoba.
- You are part of one of these programs: EPPIS, STEP, PACT, or ACT/FACTT.
- You have a schizophrenia diagnosis using standard DSM-5 criteria.
- You already agreed to be in the Manitoba Psychiatric Research (MPR) database.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at brain chemicals involved in “glutamate” and “GABA” signaling in people with schizophrenia (and separately in healthy volunteers). It may help researchers understand what’s going wrong in the brain and guide future treatments.
This study looks at how the immune system, genetics, inflammation, and past exposures may relate to bipolar disorder or schizophrenia. It may help researchers understand the cause and find better ways to support people with these conditions.
This study looks at how psychosis symptoms and development change over time in children and teens. It may help doctors better understand different patterns of illness and how to support young people with these disorders.
This study builds a database and collects samples (like blood) from people with schizophrenia to learn more about the condition. If you join, you help researchers understand schizophrenia better, which may lead to improved treatments.
This study looks at how the brain processes information in people with early psychosis compared to healthy controls. It may help improve understanding and treatment of psychosis.
This study builds a database of brain-signal measurements to help find “biomarkers” that may point to schizophrenia or related mental illnesses. Depending on whether you have a mental health diagnosis or you’re healthy, the study will collect information and brain data to compare groups.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.